Minesse (Ethinylestradiol, Gestodene | Lactose Anhydrous)

Ethinylestradiol, a synthetic estrogen, and gestodene, a progestogen, work together to inhibit the release of follicle‑stimulating and luteinizing hormones, preventing ovulation. Gestodene also thickens cervical mucus and changes the endometrial lining, reducing the chance of implantation.

The dosing regimen for Minesse is determined by the prescribing healthcare professional. Typically, it is taken as a daily tablet according to a specific cycle, but the exact schedule should follow the prescriber’s instructions.

Minesse is intended to prevent pregnancy and should not be used once pregnancy is confirmed. Its safety during breastfeeding has not been established; therefore, women should consult their healthcare provider before using it while nursing.

To order Minesse, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Minesse contains ethinylestradiol paired with gestodene, a third‑generation progestogen known for a lower androgenic profile compared with older agents like levonorgestrel. This may result in fewer androgen‑related side effects, though overall efficacy and safety remain comparable to other approved combined oral contraceptives.

Minesse tablets should be stored at ambient temperature, below 25 °C, in their original packaging to protect from moisture and light. Keep the product out of reach of children and do not use after the expiration date.

Minesse is taken orally, usually once daily at the same time each day. The tablets are swallowed whole with water and should be started according to the prescriber’s cycle schedule, often beginning on the first day of menstrual bleeding.

The most serious risks include thromboembolic events such as deep‑vein thrombosis or pulmonary embolism, hypertension, hepatic disorders, and rare but severe allergic reactions. Patients should seek immediate medical attention if they experience unexplained leg pain, chest discomfort, severe headache, or signs of an allergic reaction.

Minesse is contraindicated in women with a history of thromboembolic disease, uncontrolled hypertension, severe liver disease, known or suspected breast cancer, or those who are pregnant. It should also be avoided by smokers over 35 years of age and by individuals with known hypersensitivity to any component of the tablet.